Sunzen Biotech Berhad  >  Investor Relations Home  >  Financials  >  Financial Statements
 

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

 
Financial Statements
 
Years: 2010  |  2009  |  2008

The information is retrieved from Annual Report 2010

 
  GROUP
2010
RM
  GROUP
2009
RM
 
 
REVENUE 29,491,522   28,255,504  
 
COST OF SALES (20,169,832)   (20,064,643)  
 

GROSS PROFIT 9,321,690   8,190,861  
 
OTHER INCOME 838,589   230,249  
 

  10,160,279   8,421,110  
 
MARKETING AND DISTRIBUTION EXPENSES (3,256,255)   (3,025,651)  
 
ADMINISTRATIVE EXPENSES (2,138,940)   (2,068,384)  
 
OTHER OPERATING EXPENSES (1,801,680)   (1,031,017)  
 
FINANCE EXPENSES (445,526)   (416,828)  
 

PROFIT BEFORE TAXATION 2,517,878   1,879,230  
 
INCOME TAX EXPENSE (370,056)   (126,024)  
 

PROFIT AFTER TAXATION 2,147,822   1,753,206  
 
OTHER COMPREHENSIVE INCOME 3,187,664   -  
 

TOTAL COMPREHENSIVE INCOME FOR THE FINANCIAL YEAR 5,335,486   1,753,206  
 

PROFIT AFTER TAXATION ATTRIBUTABLE TO OWNERS OF THE COMPANY 2,147,822   1,753,206  
 

TOTAL COMPREHENSIVE INCOME ATTRIBUTABLE TO OWNERS OF THE COMPANY 5,335,486   1,753,206  
 

EARNINGS PER SHARE ATTRIBUTABLE TO OWNERS OF THE COMPANY
- Basic 1.4 sen   1.2 sen  
 

 
  GROUP
2010
RM
  GROUP
2009
RM
 
 
ASSETS
 
NON-CURRENT ASSETS
Property, plant and equipment 15,348,577   9,534,051  
Product development expenditure 1,008,704   1,436,480  
Goodwill 57,958   57,958  
Quoted investments 16,090   11,094  
 

  16,431,329   11,039,583  
 
CURRENT ASSETS
Inventories 9,998,009   10,605,126  
Trade receivables 6,128,842   7,454,838  
Other receivables and deposits 357,035   174,317  
Tax refundable 81,498   718,347  
Fixed deposits with licensed banks 4,862,154   5,248,922  
Cash and bank balances with licensed banks and other financial institution 6,538,059   4,791,325  
 

  27,965,597   28,992,875  
 

TOTAL ASSETS 44,396,926   40,032,458  
 

 
EQUITY AND LIABILITIES
 
EQUITY
Share capital 14,939,050   14,939,050  
Reserves 13,525,503   9,089,104  
 

TOTAL EQUITY 28,464,553   24,028,154  
 

 
NON-CURRENT LIABILITIES
Long-term borrowings 5,211,767   3,949,830  
Deferred taxation 522,845   452,492  
 

  5,734,612   4,402,322  
 

 
CURRENT LIABILITIES
Trade payables 4,193,871   5,487,537  
Other payables and accruals 2,406,060   2,472,680  
Amount owing to directors 33,806   27,287  
Short-term borrowings 2,667,681   3,614,478  
Dividend payable 896,343   -  
 

  10,197,761   11,601,982  
 

TOTAL LIABILITIES 15,932,373   16,004,304  
 

TOTAL EQUITY AND LIABILITIES 44,396,926   40,032,458  
 

 
NET ASSETS PER SHARE 19.05 sen   16.08 sen  
 

 
  GROUP
2010
RM
  GROUP
2009
RM
 
 
CASH FLOWS FROM / (FOR) OPERATING ACTIVITIES
Profit before taxation 2,517,878   1,879,230  
 
Adjustments for:-
Amortisation of product development expenditure 248,687   176,086  
Depreciation of property, plant and equipment 644,668   492,568  
Interest expense 412,983   393,379  
Inventories written off 508,471   -  
Product development expenditure written off 179,089   -  
Dividend income (720)   -  
Gain on disposal of plant and equipment (32,238)   (2,397)  
Interest income (132,495)   (113,671)  
Income from unit trust deposit with other financial institution (70)   -  
Unrealised gain on foreign exchange (106,362)   -  
 

Operating profit before working capital changes 4,239,891   2,825,195  
Decrease in inventories 98,646   106,785  
Decrease / (Increase) in trade and other receivables 1,295,065   (165,175)  
(Decrease) / Increase in trade and other payables (2,373,714)   1,819,869  
 

CASH FROM OPERATIONS 3,259,888   4,586,674  
Interest paid (390,707)   (393,379)  
Net tax refunded 154,408   304,304  
 

NET CASH FROM OPERATING ACTIVITIES 3,023,589   4,497,599  
 

 
CASH FLOWS (FOR) / FROM INVESTING ACTIVITIES
Dividend received 720   -  
Interest received 132,495   113,671  
Income from unit trust deposit with other financial institution 70   -  
Proceeds from disposal of plant and equipment 138,889   3,998  
Purchase of property, plant and equipment (3,065,089)   (665,550)  
Product development expenditure incurred -   (391,274)  
 

NET CASH FOR INVESTING ACTIVITIES (2,792,915)   (939,155)  
 
CASH FLOWS FROM / (FOR) FINANCING ACTIVITIES
Advances from / (Repayment to) directors 6,522   (138,662)  
Drawdown of term loans 5,557,883   -  
Repayment of hire purchase obligations (206,737)   (107,797)  
Repayment of term loans (4,228,376)   (466,086)  
Dividend paid -   (1,792,686)  
 

NET CASH FROM / (FOR) FINANCING ACTIVITIES 1,129,292   (2,505,231)  
 

 
NET INCREASE IN CASH AND CASH EQUIVALENTS 1,359,966   1,053,213  
 
CASH AND CASH EQUIVALENTS AT BEGINNING OF THE FINANCIAL YEAR 10,040,247   8,987,034  
 

CASH AND CASH EQUIVALENTS AT END OF THE FINANCIAL YEAR 11,400,213   10,040,247  
 

 

 

Quick Links

Annual Report
Download PDF
 
Quarterly Result
Download PDF
 
Email Alerts
 
 
ChartNexus Sdn Bhd © 2012 Privacy Policy | Terms of Use